Dr. B Adds New Treatments to Platform, Expands Beyond Covid-19 – MedCity News

Get the latest industry news first when you subscribe to our daily newsletter.
Consumer / Employer, Health Tech
By Marissa Plescia

Traditionally providing treatments for Covid-19, telehealth service Dr. B announced Thursday that it is adding dermatology, sexual health, reproductive health and primary care services.

New York City-based Dr. B, founded in 2021, began as an online service that matched people with unused Covid-19 vaccines. It eventually grew to provide access to Covid-19 treatments like Paxlovid and molnupiravir. The startup, available in 41 states, now offers 19 treatments, including for hair loss, eczema, birth control and more. 
While most patients pay a $15 consultation fee, the company aims to provide care for patients regardless of their financial situation. Dr. B offers its services for free to those considered eligible based on the federal poverty line, which takes into account factors like monthly income and household size. 
Expanding to treatments beyond Covid-19 was always part of the company’s plan, said Cyrus Massoumi, founder and CEO of Dr. B. 
“Access to these sorts of treatments have not been available for the masses and that’s what we’re changing,” he said in an interview.
Patients begin with a virtual health assessment, pay the consultation fee (if they’re ineligible for the no-cost option) and select their pharmacy of choice, which could be online or in-person. A medical provider then reviews the assessment, and if determined appropriate, sends a prescription to the patient’s chosen pharmacy.
The $15 fee covers the consultation, but not the treatments. Massoumi noted, however, that the $15 fee is less than most insurance copays. Dr. B is able to provide its services for such a low cost (or no cost) by relying on word-of-mouth rather than paying for advertisements, he said.
Massoumi previously founded Zocdoc, a virtual service that helps patients schedule in-person or telemedicine appointments. He started the company after having a difficult time accessing care himself for a ruptured eardrum. While Zocdoc solved some problems in healthcare, it didn’t fix everything, leading Massoumi to create Dr. B.
“[Zocdoc] did a great job of expanding access to care for those who could afford it,” he said. “How about for those who could not? … With Dr. B, that’s what we’ve been focused on for the past year and a half, which is how can we improve access to care not just for those who can afford it, but for everyone?”
Looking forward, Dr. B plans to continue adding treatments to its platform, as well as expand to additional states, Massoumi said.
“I want to be live in as many places in the country as we can be … It’s important to me that everyone in America can get access to the platform,” he said.
Companies that offer a list of treatments similar to Dr. B include Hims & Hers, Ro and Amazon through its newly launched Amazon Clinic.
Photo: elenabs, Getty Images

As hospitals face consolidation and CIOs are asked to increase staff productivity, tech companies that can support automation with solutions that are easy to onboard are getting heightened interest.
Stephanie Baum

Phone calls account for 70% of people’s first point of contact with a health system, so hospitals have sought to implement software that balances the need for speedy automation with intelligent systems that anticipate and best serve patient and care giver needs.
Stephanie Baum
, , , , ,

When it comes to contacting clinicians and patients, the hospital switchboard can be just as […]
Stephanie Baum

The Covid-19 pandemic has forced life sciences companies to take a fresh look at how they do business. But as they reinvent their operations, companies often overlook a critical function: Their learning and development programs.
Joel Berg
Our Sites
© 2023 Breaking Media, Inc. All rights reserved. Registration or use of this site constitutes acceptance of our Terms of Service and Privacy Policy.
Privacy Center | Do not sell my information
DMCA compliant image


Leave a Reply

Your email address will not be published.